Durgical
EN
Open the app

Drug eruptions: from the harmless rash to SJS/TEN

  • Disease group

Any drug can cause a rash. Most are mild, but a few kill, and the difference shows in the timing, the mucosae, skin pain, fever and blood tests.

Updated

See it in 3D: Skin

What it is

Cutaneous adverse drug reactions range from a self-limited itchy rash to life-threatening disease. The common patterns are: morbilliform (exanthematous) eruption, the most frequent; urticaria and angioedema; fixed drug eruption; photosensitivity; and the severe cutaneous adverse reactions (SCAR): drug reaction with eosinophilia and systemic symptoms (DRESS), acute generalised exanthematous pustulosis (AGEP) and Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). Each pattern has a typical delay after the drug was started, and the culprit is usually the drug started within that window.

How to recognise it

  • Morbilliform eruption: symmetric small pink macules and papules starting on the trunk, itchy, 4 to 14 days after the drug; no mucosal erosions; fades in one to two weeks after stopping.
  • Fixed drug eruption: one or a few round dusky-violet patches, sometimes blistering, that recur at the same site each time the drug is taken; lips, genitals and hands are typical; leaves brown pigment.
  • DRESS: two to eight weeks after the drug; fever, facial swelling, widespread rash, enlarged lymph nodes, eosinophilia or atypical lymphocytes and organ involvement (liver most often, kidney, lung, heart).
  • AGEP: within hours to a few days; hundreds of tiny non-follicular pustules on red skin, starting in the folds, with fever and neutrophilia; resolves quickly after stopping.
  • SJS/TEN: one to four weeks after the drug; fever and malaise first, then painful dusky or atypical target lesions, blisters and skin detachment, with erosions of two or more mucosae. SJS under 10% of body surface detached, TEN over 30%, overlap between.
  • Frequent culprits of severe reactions: allopurinol, aromatic anticonvulsants (carbamazepine, phenytoin, phenobarbital, lamotrigine), sulfonamides (including sulfamethoxazole-trimethoprim), nevirapine, oxicam anti-inflammatories and some beta-lactam antibiotics.
  • Certain HLA types raise the risk with specific drugs (for example HLA-B*58:01 with allopurinol, HLA-B*15:02 with carbamazepine in people of South-East Asian ancestry).

Drug reactions by clock and danger

PatternOnset after the drugHallmarkDanger
Urticaria / anaphylaxisMinutes to hoursWheals, angioedema, low blood pressureAirway and shock
AGEPHours to a few daysTiny pustules on red skin, folds firstUsually resolves after stopping
Morbilliform4 to 14 daysSymmetric pink macules and papules, no mucosal erosionsLow; watch for evolution
Fixed drug eruptionHours after re-exposureSame dusky patch at the same siteLow (unless generalised bullous)
SJS/TEN1 to 4 weeksSkin pain, blisters, detachment, two or more mucosaeHigh mortality
DRESS2 to 8 weeksFever, face swelling, eosinophilia, liver injuryOrgan failure

In the clinic

  • Warning signs that a «simple» drug rash is turning severe: skin pain, blisters, a positive Nikolsky sign, mucosal erosions, facial swelling, high fever, very sick patient, raised liver enzymes or eosinophils.
  • In a viral infection treated with aminopenicillins (for example infectious mononucleosis), a morbilliform rash is common and is not always a true allergy.
  • Record the culprit drug clearly as an allergy in the chart and tell the patient, so the drug and close relatives are not given again after SJS/TEN or DRESS.
  • Erythema multiforme, which also has target lesions, is usually triggered by herpes simplex rather than drugs and has typical raised targets on the hands.

Next step

  • Stop every non-essential drug started in the relevant time window; identify the most likely culprit by timing.
  • Any severe sign: complete blood count with eosinophils, liver and kidney function, and urgent hospital assessment.
  • SJS/TEN or DRESS: refer at once to hospital care (dermatology, and a burns or intensive care unit for extensive detachment); ophthalmology for eye involvement.
  • Mild morbilliform rash with no warning signs: stop the drug if possible, symptomatic treatment and review in one to two days.

Common traps

  • In a DRESS-like rash, the drug started yesterday is the culprit: the culprit was usually started weeks before.
  • A morbilliform rash is always benign: early SJS/TEN and DRESS can start the same way; look at mucosae, skin pain and blood tests.
  • After a severe reaction the culprit can be restarted cautiously: re-exposure can be fatal; it is banned for life.
  • An itchy rash under antibiotics is «allergy», no need to describe it: the pattern decides the risk and whether the patient can take the drug again.

Test yourself

Think of the answer, then tap the question to see it.

Five weeks after starting allopurinol, a man has fever, a swollen face, a widespread rash, eosinophilia and raised liver enzymes. Which reaction?

DRESS: its long delay (two to eight weeks), eosinophilia and liver involvement separate it from a simple drug rash.

A woman has the same round violet patch on her lip every time she takes a certain pain reliever. What is it?

A fixed drug eruption: it recurs at the same site with each exposure and leaves brown pigment.

Which features turn a drug rash into an emergency?

Skin pain, blisters or peeling, mucosal erosions, facial swelling, high fever, eosinophilia or organ injury.

Add to my cards (3)

Elsewhere in DurgiPedia

Connections

← All of dermatology

Educational content; it does not replace assessment by a doctor or dermatologist and is not a clinical instruction. For a rash with fever, painful skin, blisters or peeling, sores in the mouth or eyes, or a swelling throat, go to an emergency department at once.

Sources: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis (StatPearls Publishing (NCBI Bookshelf), 2024); Acute Generalized Exanthematous Pustulosis (StatPearls Publishing (NCBI Bookshelf), 2024); Erythema Multiforme (StatPearls Publishing (NCBI Bookshelf), 2024); Drug Reactions (MedlinePlus, U.S. National Library of Medicine, 2024); Stevens-Johnson syndrome/toxic epidermal necrolysis (MedlinePlus Genetics, U.S. National Library of Medicine, 2024).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.